Skip to content

QNCX QUINCE THERAPEUTICS INC COM NE

Follow

Stock (common), issuer CIK 1662774

6 managers (6 13F filers) reported a position in QNCX shares at 2026-03-31, 77,543 shares in all. 6 filers opened a position and 0 filers sold out during the quarter.

Managers
6
13F filers
6
New
6
Added
0
Reduced
0
Sold out
0
Shares held by filers
77,543

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Gen-Wealth Partners Inc33,018$3.35K<0.01%new13F-HRTimeline
Catalyst Funds Management Pty Ltd30,000$3.04K<0.01%new13F-HRTimeline
Fortitude Family Office, LLC8,095$821<0.01%new13F-HRTimeline
Advisory Services Network, LLC5,500$558<0.01%new13F-HRTimeline
Parallel Advisors, LLC795$81<0.01%new13F-HR/ATimeline
SBI Securities Co., Ltd.135$14<0.01%new13F-HRTimeline